Cycloalkyloxy-and heterocycloalkyloxypyridine compounds as modulators of the histamine H3 receptor

Details for Australian Patent Application No. 2008326561 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Letavic, Michael A.; Stocking, Emily M.

Agent Shelston IP

Pub. Number AU-A-2008326561

PCT Pub. Number WO2009/067401

Priority 60/989,246 20.11.07 US

Filing date 17 November 2008

Wipo publication date 28 May 2009

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/067401 Priority application(s): WO2009/067401

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008326569-2',4'-substituted nucleosides as antiviral agents

2008326560-Server-client interaction and information management system